MoonLake Immunotherapeutics MLTX
$15.76 $0.11 (0.69%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
MLTX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, MoonLake Immunotherapeutics is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
MoonLake Immunotherapeutics. Stock Analysis MLTX
United States Health Care Small Cap Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
MoonLake Immunotherapeutics (MLTX) Chart
Financial Metrics & Statements of MoonLake Immunotherapeutics (MLTX)
FAQ's for MoonLake Immunotherapeutics (MLTX)
- As of August 2026, MoonLake Immunotherapeutics MLTX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MoonLake Immunotherapeutics using these criteria to determine its compliance status.
- Muslim investors may consider investing in MoonLake Immunotherapeutics if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of MoonLake Immunotherapeutics by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of MoonLake Immunotherapeutics may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of MoonLake Immunotherapeutics on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for MoonLake Immunotherapeutics (MLTX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
